Flock, smart-money disclosures made readable

Oruka Therapeutics Inc

ORKANASDAQ · US

Sign in for alerts Sign in to add to portfolio

Holders

Ownership

Ownership data not yet available for this security.

Disclosure timeline

REDUCEDT+30
Klein Lawrence Otto
Oruka Therapeutics Inc · NASDAQ
−8,554 sh · $718.8K
Filed 2 Oct 2026SEC Form 4view source
ACQUIREDT+30
Klein Lawrence Otto
Oruka Therapeutics Inc · NASDAQ
+25,000 sh · $195.0K
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
Klein Lawrence Otto
Oruka Therapeutics Inc · NASDAQ
−16,246 sh · $1.4M
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
Klein Lawrence Otto
Oruka Therapeutics Inc · NASDAQ
−200 sh · $17.0K
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
Quinlan Paul T
Oruka Therapeutics Inc · NASDAQ
−601 sh · $56.8K
Filed 21 Sept 2026SEC Form 4view source
REDUCEDT+30
Quinlan Paul T
Oruka Therapeutics Inc · NASDAQ
−3,832 sh · $357.6K
Filed 21 Sept 2026SEC Form 4view source
REDUCEDT+30
Quinlan Paul T
Oruka Therapeutics Inc · NASDAQ
−2,667 sh · $254.2K
Filed 21 Sept 2026SEC Form 4view source
ACQUIREDT+30
Quinlan Paul T
Oruka Therapeutics Inc · NASDAQ
+10,000 sh · $78.0K
Filed 21 Sept 2026SEC Form 4view source
REDUCEDT+30
Agarwal Arjun
Oruka Therapeutics Inc · NASDAQ
−533 sh · $51.0K
Filed 21 Sept 2026SEC Form 4view source
REDUCEDT+30
Quinlan Paul T
Oruka Therapeutics Inc · NASDAQ
−2,900 sh · $267.9K
Filed 21 Sept 2026SEC Form 4view source

Announcements

No announcements on record for this security.

Show all 40 disclosures

ACQUIREDT+30
Goncalves Joana
Oruka Therapeutics Inc · NASDAQ
+3,500 sh · $27.3K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Agarwal Arjun
Oruka Therapeutics Inc · NASDAQ
−3,000 sh · $273.3K
Filed 15 Sept 2026SEC Form 4view source
ACQUIREDT+30
Goncalves Joana
Oruka Therapeutics Inc · NASDAQ
+3,500 sh · $23.9K
Filed 15 Sept 2026SEC Form 4view source
ACQUIREDT+30
Agarwal Arjun
Oruka Therapeutics Inc · NASDAQ
+8,000 sh · $100.0K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Agarwal Arjun
Oruka Therapeutics Inc · NASDAQ
−560 sh · $53.6K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Klein Lawrence Otto
Oruka Therapeutics Inc · NASDAQ
−2,452 sh · $234.7K
Filed 15 Sept 2026SEC Form 4view source
ACQUIREDT+30
Agarwal Arjun
Oruka Therapeutics Inc · NASDAQ
+1,459 sh · $50.2K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Agarwal Arjun
Oruka Therapeutics Inc · NASDAQ
−2,208 sh · $205.9K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Goncalves Joana
Oruka Therapeutics Inc · NASDAQ
−1,366 sh · $127.0K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Goncalves Joana
Oruka Therapeutics Inc · NASDAQ
−947 sh · $90.6K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Goncalves Joana
Oruka Therapeutics Inc · NASDAQ
−3,150 sh · $289.9K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Quinlan Paul T
Oruka Therapeutics Inc · NASDAQ
−1,039 sh · $99.4K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Goncalves Joana
Oruka Therapeutics Inc · NASDAQ
−2,384 sh · $217.2K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Goncalves Joana
Oruka Therapeutics Inc · NASDAQ
−100 sh · $9.4K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Agarwal Arjun
Oruka Therapeutics Inc · NASDAQ
−200 sh · $18.8K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Sandler Laura Lee
Oruka Therapeutics Inc · NASDAQ
−906 sh · $86.7K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Agarwal Arjun
Oruka Therapeutics Inc · NASDAQ
−4,051 sh · $374.4K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDStale
Klein Lawrence Otto
Oruka Therapeutics Inc · NASDAQ
−6,604 sh · $599.6K
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Klein Lawrence Otto
Oruka Therapeutics Inc · NASDAQ
−63,596 sh · $5.8M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Klein Lawrence Otto
Oruka Therapeutics Inc · NASDAQ
−4,800 sh · $443.7K
Filed 1 Sept 2026SEC Form 4view source
ACQUIREDStale
Klein Lawrence Otto
Oruka Therapeutics Inc · NASDAQ
+75,000 sh · $585.0K
Filed 1 Sept 2026SEC Form 4view source
ACQUIREDStale
Sandler Laura Lee
Oruka Therapeutics Inc · NASDAQ
+5,000 sh · $39.0K
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Sandler Laura Lee
Oruka Therapeutics Inc · NASDAQ
−4,000 sh · $368.1K
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Sandler Laura Lee
Oruka Therapeutics Inc · NASDAQ
−1,000 sh · $91.0K
Filed 1 Sept 2026SEC Form 4view source
ACQUIREDStale
Edwards Larry Todd
Oruka Therapeutics Inc · NASDAQ
+100,000 sh
Filed 25 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Viking Global Investors
Oruka Therapeutics Inc · NASDAQ
1,503,478 sh · $143.1M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDStale
Viking Global Investors
Oruka Therapeutics Inc · NASDAQ
2,666,690 sh · $130.8M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Oruka Therapeutics Inc · NASDAQ
19,364 sh · $949.8K
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Viking Global Investors
Oruka Therapeutics Inc · NASDAQ
2,666,690 sh · $80.8M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Viking Global Investors
Oruka Therapeutics Inc · NASDAQ
2,666,690 sh · $51.3M
Filed 30 Sept 2025SEC 13Fview source